MD Biosciences
April 12, 2018: In the Know
April 11, 2018 | Tags: ANI Pharmaceuticals, CHF Solutions, Collagen Solutions, Coloplast, DiaMedica, Global Kinetics, Inspire Medical Systems, InterRad Medical, Magenta Therapeutics, Mayo Clinic, MD Biosciences, Rebiotix, University of Minnesota, vidscrip, Zipnosis
SecurAcath Selected for Fast-Track NHS Use Through New Innovation and Technology Payment Program
Ferring acquires innovative biotechnology company and microbiome pioneer Rebiotix Inc.
University of Minnesota wins $42 million in federal funds for biomedical research
Medtech start-up Global Kinetics scores first BTF investment, kicks off new trial
CHF
Coloplast Expands its Product Portfolio With New Innovative Ostomy Category
State-funded consortium provides more access statewide to clinical trials for cancer
How CHF Solutions is using health economics to expand product adoption
In Minneapolis, the Spotlight is on “The Silicon Valley of the Midwest”
DiaMedica Therapeutics Announces Appointment of Scott Kellen as Chief Financial Officer
ANI Acquires 23 ANDAs from IDT Australia, Ltd.
Progress MN: MD Biosciences Inc.
Louis T. Ruggiero Named CBO of Collagen Solutions Plc
Vidscrip, Zipnosis Team Up to Personalize the Virtual Care Experience
